Prostate Cancer clinical trials in New Hampshire

3 actively recruiting prostate cancer trials at 1 site across New Hampshire.

Data from ClinicalTrials.gov · last refreshed 2026-08-10

Phase 3 Recruiting Academic/Other

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk …

Sponsor: NRG Oncology

NCT ID: NCT05946213

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better o…

Sponsor: Canadian Cancer Trials Group

NCT ID: NCT06592924

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

The goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer patients. Stereotactic body radiotherapy (SBRT) alone or Stereotactic body radiotherapy (SBRT) combined…

Sponsor: Yale University

NCT ID: NCT06111781

Sites in New Hampshire:

Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-08-10